Moderate risk individuals include those over 40 with minor family history, those slightly behind on screening, or those using BPC-157 for moderate rather than severe healing needs
Understanding these genetic factors can support a provider conversation about realistic expectations, potential dose requirements, and whether GLP-1 is a good fit alongside other lifestyle modifications or complementary approaches
Central precocious puberty (PP) appears to occur more often in girls with mitochondrial diseases than in the general population, resulting in increased sex hormone levels (especially estradiol) and advanced bone age compared with chronological age
Changes must be made, but those changes must be well thought out, meaningful, and humane
The prospect of funding lifelong drug regimens for large populations is financially daunting and raises concerns about long-term sustainability